Medical Disclaimer Educational Purposes Only: The information provided on this page is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment
These are clinical outcomes data that also represent commercial outcomes for manufacturers: every treatment delay is a missed prescription fill
Neurotransmitter Modulation GLP-1 agonists may also influence neurotransmitter systems involved in pain perception
That is why they are more accurately viewed as metabolic and satiety-regulating medications, not simple appetite suppressants
7 Researchers have also investigated the potential utility of combining GLP-1 with sodium-glucose cotransporter-2 (SGLT-2) inhibitors, amylin analogs, or central appetite modulators
(6) M H Rasmussen, J Frystyk, T Andersen, L Breum, et al (1994) The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone Metabolism, 1994 Mar, Volume 43 (Issue 3), Pages 315-9